Announcements Trials
Browse Landscape

Phase

Phase NA 9Phase 3 6Phase 4 4Phase 1 4Phase EARLY_PHASE1 2Phase 2 2Phase 1/2 1

Status

Completed 2

Sponsor Class

OTHER 35INDUSTRY 2

Study Type

Interventional 2

Sponsor

Cancer Type

CNS 1

Conditions

Papillomavirus Infections 1Glioblastoma 1

Interventions

Carboplatin 272Paclitaxel 267Gemcitabine 244Bevacizumab 225Cisplatin 216pembrolizumab 213Docetaxel 210Pemetrexed 162Capecitabine 148Fluorouracil 129Oxaliplatin 121Cyclophosphamide 121Nivolumab 112Dexamethasone 99Trastuzumab 89Leucovorin 87Cetuximab 85Rituximab 83Irinotecan 82Injections 80Erlotinib Hydrochloride 70Prednisone 68Doxorubicin 68Temozolomide 67atezolizumab 65Ipilimumab 64Bortezomib 64Fulvestrant 59Radiotherapy 54Drug Therapy 51

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 2 × INDUSTRY × Blood Specimen Collection × Clear all
NCT00518336 2016-12-09

Follow-up Study to Evaluate the Long-term Efficacy of the HPV Vaccine (580299) in Healthy Young Adult Women in Brazil

GlaxoSmithKline

Phase 2 Completed
433 enrolled 66 charts

Papillomavirus Infections

NCT01071837 2015-06-16

APG101 in Glioblastoma

Apogenix AG

Phase 2 Completed
84 enrolled
CNS

Glioblastoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡